CF vs VRTX · P/E 12, rev $5.94B vs P/E 30, rev $12.00B
CF Industries Holdings Inc (CF) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CF currently screens at market cap $14.98B and trailing P/E 12.2. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CF and VRTX stock pages for the full models.
Not investment advice.